Quality of diabetes care in Norwegian general practice;Kvaliteten på diabetesbehandlingen i allmennpraksis

Tidsskrift for den Norske Laegeforening

Volumn 128, Issue 22, 2008, Pages 2570-2574

  Claudi, Tor ^a   Ingskog, Wibeche ^b   Cooper, John G ^c   Jenum, Anne Karen ^b   Hausken, Marie Fjelde ^c  

^a Medisinsk Avdeling   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

^c Stavanger Universitetssjukehus ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET THERAPY; FEMALE; GENERAL PRACTICE; HEALTH CARE QUALITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; STANDARD;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FAMILY PRACTICE; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIFE STYLE; MALE; MIDDLE AGED; NORWAY; PRIMARY HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE;

EID: 56749185394     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Midthjell K, Krüger ∅, Holmen J et al. Rapid changes in the prevalence of obesity and known diabetes mellitus in an adult Norwegian population. Diabetes Care 1999; 22; 1813-20.
2. Wild S, Roglic G, Green A et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
3. Nasjonal strategi for diabetesområdet 2006-2010. www.regjeringen.no/nb/dep/hod/dok/rapporter_planer/rapporter/2006/ Nasjonal-strategi-for-diabetesomradet-2006-2010.html?id=106611 (24.6.2008).
4. Gæde P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-93.
5. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317: 703-13.
6. Pyörälä K, Pedersen TR, Kjekshus J et al. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20: 614-20.
7. The CARE Investigators. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial survivors with average cholesterol levels: subgroup analysis in the cholesterol and recurrent events (CARE) trial. Circulation 1998; 23: 2513-9.
8. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-57.
9. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterollowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361: 2005-16.
10. Tuomilehto J, Lindström J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
11. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestile intervention or metformin. N Engl J Med 2002; 346: 393-403.
12. Johansen OE, Gullestad L, Blaasaas KG et al. Effects of structured hospital based care compared with standard care for type 2 diabetes - The Asker and Baerum Cardiovascular Diabetes Study, an randomized trial. Diabet Med 2007; doi: 10.1111/j1464-491.2007.02198x.
13. Claudi T, Cooper J, Skogøy K et al. Diabetesomsorg i norsk allmennpraksis. En tilstandsrapport fra Salten og deler av Rogaland. Tidsskr Nor Lægeforen 1997; 25: 3661-4.
14. Claudi T, Cooper JG, Hausken MF et al. Risikointervensjon ved diabetes i allmennpraksis. Tidsskr Nor Lægeforen 2004; 124: 1508-10.
15. Claudi T, Cooper JG, Midthjell K et al. NSAMs handlingsprogram for diabetes i allmennpraksis. Oslo: Norsk selskap for allmennmedisin, Norges Diabetesforbund, Statens helsetilsyn, Statens institutt for folkehelse, Den norske lægeforening, 2005. www.nsamdiabetes.no (24.6.2008).
16. Jeffcoate WJ, van Houtum WH. Amputation as a marker of the quality of foot care in diabetes. Diabetologia 2004; 47: 2051-8.
17. UK Prospective Diabetes Study (UKPDS) group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with diabetes (UKPDS 33). Lancet 1998; 352: 837-52.
18. Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycemia in type 2 diabetes: a concensus algorithm for the initation and ajustment of therapy. A concensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963-71.
19. UK Prospective Diabetes Study group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 30. BMJ 1998; 317: 703-12.
20. IDF Clinical Guidelines Task Force. Global guideline for type 2 diabetes. Brussel: International Diabetes Federation, 2005.
21. Ulset E, Undheim R, Malterud K. Er fedmeepidemien kommet til Norge? Tidsskr Nor Lægeforen 2007; 127: 34-7.
22. Jenum AK, Graff-Iversen S, Selmer R et al. Risikofaktorer for hjerte- og karsykdom og diabetes gjennom 30 år. Tidsskr Nor Lægeforen 2007; 127: 2532-6.
23. Treweek S, Flottorp S, Fretheim A et al. Retningslinjer for allmennpraksis - blir de lest og blir de brukt? Tidsskr Nor Lægeforen 2005; 125: 300-3.
24. Norsk diabetesregister for voksne - et bedre liv med diabetes. www.uib.no/isf/noklus/diabetesregister/ (24.6.2008).